GERN Q3 2021 Earnings — Geron Corporation Revenue & Financial Results | Market Cap Arena

GERNGeron Corporation

$1B

Q3 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$109,000+0.9% YoY

Gross Profit

-$18M-16897.2% margin

Operating Income

-$26M-23554.1% margin

Net Income

-$27M-24492.7% margin

EPS (Diluted)

$-0.08

QoQ Revenue Growth

+1.9%

Cash Flow

Operating Cash Flow

-$23M

Free Cash Flow

-$23M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$229M

Total Liabilities

$78M

Stockholders' Equity

$152M

Cash & Equivalents

$29M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$109,000	$108,000	+0.9%
Gross Profit	-$18M	$108,000	-17153.7%
Operating Income	-$26M	-$20M	-28.3%
Net Income	-$27M	-$20M	-35.9%